Augmedix Statistics
Total Valuation
TSXV:IB has a market cap or net worth of CAD 5.72 million. The enterprise value is 24.33 million.
Market Cap | 5.72M |
Enterprise Value | 24.33M |
Important Dates
The next estimated earnings date is Tuesday, October 28, 2025.
Earnings Date | Oct 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSXV:IB has 114.43 million shares outstanding. The number of shares has increased by 6.43% in one year.
Current Share Class | 114.43M |
Shares Outstanding | 114.43M |
Shares Change (YoY) | +6.43% |
Shares Change (QoQ) | +0.20% |
Owned by Insiders (%) | 24.70% |
Owned by Institutions (%) | 1.64% |
Float | 85.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.20 |
PB Ratio | 1.69 |
P/TBV Ratio | 1.69 |
P/FCF Ratio | 0.95 |
P/OCF Ratio | 0.86 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.33, with an EV/FCF ratio of 4.03.
EV / Earnings | -6.10 |
EV / Sales | 0.85 |
EV / EBITDA | 17.33 |
EV / EBIT | 52.73 |
EV / FCF | 4.03 |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 5.69.
Current Ratio | 0.76 |
Quick Ratio | 0.19 |
Debt / Equity | 5.69 |
Debt / EBITDA | 13.68 |
Debt / FCF | 3.18 |
Interest Coverage | 0.17 |
Financial Efficiency
Return on equity (ROE) is -55.05% and return on invested capital (ROIC) is 1.09%.
Return on Equity (ROE) | -55.05% |
Return on Assets (ROA) | 0.82% |
Return on Invested Capital (ROIC) | 1.09% |
Return on Capital Employed (ROCE) | 4.76% |
Revenue Per Employee | 757,483 |
Profits Per Employee | -104,889 |
Employee Count | 58 |
Asset Turnover | 0.82 |
Inventory Turnover | 1.81 |
Taxes
Income Tax | -28,747 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.67% in the last 52 weeks. The beta is 1.18, so TSXV:IB's price volatility has been higher than the market average.
Beta (5Y) | 1.18 |
52-Week Price Change | -16.67% |
50-Day Moving Average | 0.06 |
200-Day Moving Average | 0.08 |
Relative Strength Index (RSI) | 41.56 |
Average Volume (20 Days) | 17,866 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:IB had revenue of CAD 28.78 million and -3.99 million in losses. Loss per share was -0.04.
Revenue | 28.78M |
Gross Profit | 6.34M |
Operating Income | 461,389 |
Pretax Income | -2.72M |
Net Income | -3.99M |
EBITDA | 1.40M |
EBIT | 461,389 |
Loss Per Share | -0.04 |
Balance Sheet
The company has 600,812 in cash and 19.21 million in debt, giving a net cash position of -18.61 million or -0.16 per share.
Cash & Cash Equivalents | 600,812 |
Total Debt | 19.21M |
Net Cash | -18.61M |
Net Cash Per Share | -0.16 |
Equity (Book Value) | 3.38M |
Book Value Per Share | 0.03 |
Working Capital | -4.92M |
Cash Flow
In the last 12 months, operating cash flow was 6.69 million and capital expenditures -648,245, giving a free cash flow of 6.04 million.
Operating Cash Flow | 6.69M |
Capital Expenditures | -648,245 |
Free Cash Flow | 6.04M |
FCF Per Share | 0.05 |
Margins
Gross margin is 22.03%, with operating and profit margins of 1.60% and -13.85%.
Gross Margin | 22.03% |
Operating Margin | 1.60% |
Pretax Margin | -9.44% |
Profit Margin | -13.85% |
EBITDA Margin | 4.88% |
EBIT Margin | 1.60% |
FCF Margin | 20.99% |
Dividends & Yields
TSXV:IB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.43% |
Shareholder Yield | n/a |
Earnings Yield | -69.66% |
FCF Yield | 105.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 24, 2016. It was a reverse split with a ratio of 0.1.
Last Split Date | May 24, 2016 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
TSXV:IB has an Altman Z-Score of -3.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.72 |
Piotroski F-Score | 5 |